Gilead Sciences (GILD) R&D In Process (2019 - 2025)
Historic R&D In Process for Gilead Sciences (GILD) over the last 7 years, with Q3 2025 value amounting to $170.0 million.
- Gilead Sciences' R&D In Process fell 6633.66% to $170.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $473.0 million, marking a year-over-year decrease of 9057.96%. This contributed to the annual value of $4.7 billion for FY2024, which is 30372.29% up from last year.
- As of Q3 2025, Gilead Sciences' R&D In Process stood at $170.0 million, which was down 6633.66% from $61.0 million recorded in Q2 2025.
- Gilead Sciences' 5-year R&D In Process high stood at $4.1 billion for Q1 2024, and its period low was -$11.0 million during Q4 2024.
- For the 5-year period, Gilead Sciences' R&D In Process averaged around $430.5 million, with its median value being $170.0 million (2025).
- Its R&D In Process has fluctuated over the past 5 years, first skyrocketed by 591250.0% in 2023, then tumbled by 10317.0% in 2024.
- Quarter analysis of 5 years shows Gilead Sciences' R&D In Process stood at $669.0 million in 2021, then plummeted by 76.38% to $158.0 million in 2022, then soared by 119.62% to $347.0 million in 2023, then plummeted by 103.17% to -$11.0 million in 2024, then surged by 1645.45% to $170.0 million in 2025.
- Its R&D In Process was $170.0 million in Q3 2025, compared to $61.0 million in Q2 2025 and $253.0 million in Q1 2025.